CD36 and obstructive sleep apnea syndrome: The novelty of our present study is that both CD36 expression and the degree of steatosis are increased in livers from animal models of IH and in patients with OSA featured by nocturnal IH, supporting the notion that CD36 could be a key factor driving hepatosteatosis in OSA patients.